nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Alkylating Activity—Dacarbazine—pancreatic cancer	0.455	1	CiPCiCtD
Ifosfamide—germ cell cancer—pancreatic cancer	0.291	1	CtDrD
Ifosfamide—CYP2A6—Tamoxifen—pancreatic cancer	0.0146	0.0823	CbGbCtD
Ifosfamide—CYP2A6—Fluorouracil—pancreatic cancer	0.0107	0.0607	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.00995	0.0563	CbGbCtD
Ifosfamide—CYP3A7—Tamoxifen—pancreatic cancer	0.00995	0.0563	CbGbCtD
Ifosfamide—CYP2B6—Tamoxifen—pancreatic cancer	0.00947	0.0536	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.00764	0.0432	CbGbCtD
Ifosfamide—CYP3A7—Irinotecan—pancreatic cancer	0.00764	0.0432	CbGbCtD
Ifosfamide—CYP3A5—Tamoxifen—pancreatic cancer	0.00746	0.0422	CbGbCtD
Ifosfamide—CYP2B6—Irinotecan—pancreatic cancer	0.00728	0.0411	CbGbCtD
Ifosfamide—CYP2C8—Tamoxifen—pancreatic cancer	0.00718	0.0406	CbGbCtD
Ifosfamide—CYP3A5—Erlotinib—pancreatic cancer	0.00635	0.0359	CbGbCtD
Ifosfamide—CYP2C8—Erlotinib—pancreatic cancer	0.0061	0.0345	CbGbCtD
Ifosfamide—CYP2C19—Tamoxifen—pancreatic cancer	0.00602	0.0341	CbGbCtD
Ifosfamide—CYP3A5—Irinotecan—pancreatic cancer	0.00573	0.0324	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—pancreatic cancer	0.0056	0.0317	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0056	0.0317	CbGbCtD
Ifosfamide—CYP3A7—Sunitinib—pancreatic cancer	0.00557	0.0315	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00557	0.0315	CbGbCtD
Ifosfamide—CYP2C8—Fluorouracil—pancreatic cancer	0.00529	0.0299	CbGbCtD
Ifosfamide—CYP2C9—Tamoxifen—pancreatic cancer	0.00501	0.0283	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—pancreatic cancer	0.0042	0.0238	CbGbCtD
Ifosfamide—CYP3A5—Sunitinib—pancreatic cancer	0.00418	0.0236	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—pancreatic cancer	0.00397	0.0225	CbGbCtD
Ifosfamide—CYP2C9—Fluorouracil—pancreatic cancer	0.00369	0.0209	CbGbCtD
Ifosfamide—CYP3A4—Tamoxifen—pancreatic cancer	0.00291	0.0165	CbGbCtD
Ifosfamide—CYP3A4—Erlotinib—pancreatic cancer	0.00247	0.014	CbGbCtD
Ifosfamide—CYP3A4—Irinotecan—pancreatic cancer	0.00223	0.0126	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—pancreatic cancer	0.00164	0.00926	CbGbCtD
Ifosfamide—CYP3A4—Sunitinib—pancreatic cancer	0.00163	0.00922	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—pancreatic cancer	0.00122	0.00691	CbGbCtD
Ifosfamide—Breast disorder—Doxorubicin—pancreatic cancer	2.41e-05	0.000316	CcSEcCtD
Ifosfamide—Body temperature increased—Irinotecan—pancreatic cancer	2.41e-05	0.000315	CcSEcCtD
Ifosfamide—Abdominal pain—Irinotecan—pancreatic cancer	2.41e-05	0.000315	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	2.41e-05	0.000315	CcSEcCtD
Ifosfamide—Feeling abnormal—Fluorouracil—pancreatic cancer	2.4e-05	0.000315	CcSEcCtD
Ifosfamide—Anaemia—Docetaxel—pancreatic cancer	2.38e-05	0.000312	CcSEcCtD
Ifosfamide—Pancytopenia—Epirubicin—pancreatic cancer	2.37e-05	0.00031	CcSEcCtD
Ifosfamide—Vomiting—Sunitinib—pancreatic cancer	2.35e-05	0.000308	CcSEcCtD
Ifosfamide—Body temperature increased—Gemcitabine—pancreatic cancer	2.34e-05	0.000307	CcSEcCtD
Ifosfamide—Dysuria—Epirubicin—pancreatic cancer	2.33e-05	0.000306	CcSEcCtD
Ifosfamide—Rash—Sunitinib—pancreatic cancer	2.33e-05	0.000305	CcSEcCtD
Ifosfamide—Dermatitis—Sunitinib—pancreatic cancer	2.33e-05	0.000305	CcSEcCtD
Ifosfamide—Urticaria—Fluorouracil—pancreatic cancer	2.32e-05	0.000303	CcSEcCtD
Ifosfamide—Leukopenia—Docetaxel—pancreatic cancer	2.31e-05	0.000302	CcSEcCtD
Ifosfamide—Pollakiuria—Epirubicin—pancreatic cancer	2.3e-05	0.000302	CcSEcCtD
Ifosfamide—Body temperature increased—Fluorouracil—pancreatic cancer	2.3e-05	0.000302	CcSEcCtD
Ifosfamide—Palpitations—Docetaxel—pancreatic cancer	2.28e-05	0.000298	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—pancreatic cancer	2.26e-05	0.000297	CcSEcCtD
Ifosfamide—Hyperglycaemia—Epirubicin—pancreatic cancer	2.25e-05	0.000295	CcSEcCtD
Ifosfamide—Cough—Docetaxel—pancreatic cancer	2.25e-05	0.000295	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—pancreatic cancer	2.25e-05	0.000295	CcSEcCtD
Ifosfamide—Hypersensitivity—Irinotecan—pancreatic cancer	2.24e-05	0.000294	CcSEcCtD
Ifosfamide—Pneumonia—Epirubicin—pancreatic cancer	2.24e-05	0.000293	CcSEcCtD
Ifosfamide—Convulsion—Docetaxel—pancreatic cancer	2.23e-05	0.000293	CcSEcCtD
Ifosfamide—Hypertension—Docetaxel—pancreatic cancer	2.23e-05	0.000292	CcSEcCtD
Ifosfamide—Infestation NOS—Epirubicin—pancreatic cancer	2.22e-05	0.000291	CcSEcCtD
Ifosfamide—Infestation—Epirubicin—pancreatic cancer	2.22e-05	0.000291	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	2.21e-05	0.000289	CcSEcCtD
Ifosfamide—Arthralgia—Docetaxel—pancreatic cancer	2.19e-05	0.000287	CcSEcCtD
Ifosfamide—Chest pain—Docetaxel—pancreatic cancer	2.19e-05	0.000287	CcSEcCtD
Ifosfamide—Myalgia—Docetaxel—pancreatic cancer	2.19e-05	0.000287	CcSEcCtD
Ifosfamide—Nausea—Sunitinib—pancreatic cancer	2.19e-05	0.000287	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—pancreatic cancer	2.19e-05	0.000287	CcSEcCtD
Ifosfamide—Renal failure—Epirubicin—pancreatic cancer	2.19e-05	0.000286	CcSEcCtD
Ifosfamide—Asthenia—Irinotecan—pancreatic cancer	2.18e-05	0.000286	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.18e-05	0.000286	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.18e-05	0.000285	CcSEcCtD
Ifosfamide—Stomatitis—Epirubicin—pancreatic cancer	2.17e-05	0.000284	CcSEcCtD
Ifosfamide—Conjunctivitis—Epirubicin—pancreatic cancer	2.16e-05	0.000283	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—pancreatic cancer	2.16e-05	0.000283	CcSEcCtD
Ifosfamide—Hypersensitivity—Fluorouracil—pancreatic cancer	2.15e-05	0.000281	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—pancreatic cancer	2.13e-05	0.000279	CcSEcCtD
Ifosfamide—Asthenia—Gemcitabine—pancreatic cancer	2.13e-05	0.000279	CcSEcCtD
Ifosfamide—Haematuria—Epirubicin—pancreatic cancer	2.12e-05	0.000278	CcSEcCtD
Ifosfamide—Confusional state—Docetaxel—pancreatic cancer	2.12e-05	0.000278	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Epirubicin—pancreatic cancer	2.1e-05	0.000276	CcSEcCtD
Ifosfamide—Anaphylactic shock—Docetaxel—pancreatic cancer	2.1e-05	0.000276	CcSEcCtD
Ifosfamide—Oedema—Docetaxel—pancreatic cancer	2.1e-05	0.000276	CcSEcCtD
Ifosfamide—Pruritus—Gemcitabine—pancreatic cancer	2.1e-05	0.000275	CcSEcCtD
Ifosfamide—Infection—Docetaxel—pancreatic cancer	2.09e-05	0.000274	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—pancreatic cancer	2.08e-05	0.000273	CcSEcCtD
Ifosfamide—Diarrhoea—Irinotecan—pancreatic cancer	2.08e-05	0.000273	CcSEcCtD
Ifosfamide—Agranulocytosis—Epirubicin—pancreatic cancer	2.08e-05	0.000272	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—pancreatic cancer	2.07e-05	0.000271	CcSEcCtD
Ifosfamide—Nervous system disorder—Docetaxel—pancreatic cancer	2.06e-05	0.00027	CcSEcCtD
Ifosfamide—Pruritus—Fluorouracil—pancreatic cancer	2.06e-05	0.00027	CcSEcCtD
Ifosfamide—Thrombocytopenia—Docetaxel—pancreatic cancer	2.06e-05	0.00027	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—pancreatic cancer	2.06e-05	0.00027	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—pancreatic cancer	2.06e-05	0.00027	CcSEcCtD
Ifosfamide—Skin disorder—Docetaxel—pancreatic cancer	2.04e-05	0.000268	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	2.04e-05	0.000267	CcSEcCtD
Ifosfamide—Bradycardia—Epirubicin—pancreatic cancer	2.03e-05	0.000266	CcSEcCtD
Ifosfamide—Diarrhoea—Gemcitabine—pancreatic cancer	2.03e-05	0.000266	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—pancreatic cancer	2.02e-05	0.000265	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.02e-05	0.000264	CcSEcCtD
Ifosfamide—Dizziness—Irinotecan—pancreatic cancer	2.01e-05	0.000264	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—pancreatic cancer	2.01e-05	0.000263	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—pancreatic cancer	2.01e-05	0.000263	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—pancreatic cancer	2.01e-05	0.000263	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—pancreatic cancer	2e-05	0.000262	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—pancreatic cancer	2e-05	0.000262	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—pancreatic cancer	2e-05	0.000262	CcSEcCtD
Ifosfamide—Diarrhoea—Fluorouracil—pancreatic cancer	1.99e-05	0.000261	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—pancreatic cancer	1.97e-05	0.000258	CcSEcCtD
Ifosfamide—Hypotension—Docetaxel—pancreatic cancer	1.97e-05	0.000257	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—pancreatic cancer	1.96e-05	0.000257	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—pancreatic cancer	1.96e-05	0.000257	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—pancreatic cancer	1.96e-05	0.000256	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	1.95e-05	0.000255	CcSEcCtD
Ifosfamide—Vomiting—Irinotecan—pancreatic cancer	1.93e-05	0.000253	CcSEcCtD
Ifosfamide—Dizziness—Fluorouracil—pancreatic cancer	1.93e-05	0.000252	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—pancreatic cancer	1.92e-05	0.000252	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—pancreatic cancer	1.92e-05	0.000252	CcSEcCtD
Ifosfamide—Rash—Irinotecan—pancreatic cancer	1.92e-05	0.000251	CcSEcCtD
Ifosfamide—Dermatitis—Irinotecan—pancreatic cancer	1.92e-05	0.000251	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	1.92e-05	0.000251	CcSEcCtD
Ifosfamide—Paraesthesia—Docetaxel—pancreatic cancer	1.89e-05	0.000247	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—pancreatic cancer	1.89e-05	0.000247	CcSEcCtD
Ifosfamide—Vomiting—Gemcitabine—pancreatic cancer	1.88e-05	0.000247	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—pancreatic cancer	1.88e-05	0.000246	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—pancreatic cancer	1.88e-05	0.000246	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—pancreatic cancer	1.87e-05	0.000245	CcSEcCtD
Ifosfamide—Rash—Gemcitabine—pancreatic cancer	1.87e-05	0.000245	CcSEcCtD
Ifosfamide—Dermatitis—Gemcitabine—pancreatic cancer	1.87e-05	0.000245	CcSEcCtD
Ifosfamide—Eye disorder—Epirubicin—pancreatic cancer	1.87e-05	0.000244	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—pancreatic cancer	1.86e-05	0.000244	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—pancreatic cancer	1.86e-05	0.000243	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—pancreatic cancer	1.85e-05	0.000243	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—pancreatic cancer	1.85e-05	0.000243	CcSEcCtD
Ifosfamide—Vomiting—Fluorouracil—pancreatic cancer	1.85e-05	0.000243	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—pancreatic cancer	1.85e-05	0.000242	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—pancreatic cancer	1.85e-05	0.000242	CcSEcCtD
Ifosfamide—Rash—Fluorouracil—pancreatic cancer	1.84e-05	0.000241	CcSEcCtD
Ifosfamide—Dermatitis—Fluorouracil—pancreatic cancer	1.84e-05	0.000241	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—pancreatic cancer	1.83e-05	0.00024	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	1.82e-05	0.000239	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	1.82e-05	0.000238	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—pancreatic cancer	1.82e-05	0.000238	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—pancreatic cancer	1.81e-05	0.000238	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—pancreatic cancer	1.81e-05	0.000237	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—pancreatic cancer	1.81e-05	0.000237	CcSEcCtD
Ifosfamide—Nausea—Irinotecan—pancreatic cancer	1.81e-05	0.000237	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—pancreatic cancer	1.8e-05	0.000236	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—pancreatic cancer	1.8e-05	0.000236	CcSEcCtD
Ifosfamide—Pain—Docetaxel—pancreatic cancer	1.8e-05	0.000236	CcSEcCtD
Ifosfamide—Constipation—Docetaxel—pancreatic cancer	1.8e-05	0.000236	CcSEcCtD
Ifosfamide—Chills—Epirubicin—pancreatic cancer	1.79e-05	0.000235	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—pancreatic cancer	1.78e-05	0.000234	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—pancreatic cancer	1.78e-05	0.000233	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—pancreatic cancer	1.76e-05	0.000231	CcSEcCtD
Ifosfamide—Nausea—Gemcitabine—pancreatic cancer	1.76e-05	0.000231	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—pancreatic cancer	1.75e-05	0.000229	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—pancreatic cancer	1.75e-05	0.000229	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—pancreatic cancer	1.74e-05	0.000228	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—pancreatic cancer	1.74e-05	0.000228	CcSEcCtD
Ifosfamide—Feeling abnormal—Docetaxel—pancreatic cancer	1.73e-05	0.000227	CcSEcCtD
Ifosfamide—Nausea—Fluorouracil—pancreatic cancer	1.73e-05	0.000227	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—pancreatic cancer	1.73e-05	0.000226	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—pancreatic cancer	1.72e-05	0.000226	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.72e-05	0.000225	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—pancreatic cancer	1.71e-05	0.000225	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—pancreatic cancer	1.71e-05	0.000225	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—pancreatic cancer	1.68e-05	0.00022	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—pancreatic cancer	1.67e-05	0.000219	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.67e-05	0.000218	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—pancreatic cancer	1.66e-05	0.000218	CcSEcCtD
Ifosfamide—Abdominal pain—Docetaxel—pancreatic cancer	1.66e-05	0.000218	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—pancreatic cancer	1.66e-05	0.000217	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—pancreatic cancer	1.65e-05	0.000216	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—pancreatic cancer	1.64e-05	0.000215	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—pancreatic cancer	1.63e-05	0.000214	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—pancreatic cancer	1.62e-05	0.000212	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—pancreatic cancer	1.61e-05	0.000211	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—pancreatic cancer	1.61e-05	0.000211	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—pancreatic cancer	1.61e-05	0.000211	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—pancreatic cancer	1.61e-05	0.00021	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—pancreatic cancer	1.6e-05	0.000209	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—pancreatic cancer	1.57e-05	0.000205	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—pancreatic cancer	1.56e-05	0.000205	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—pancreatic cancer	1.56e-05	0.000204	CcSEcCtD
Ifosfamide—Hypersensitivity—Docetaxel—pancreatic cancer	1.55e-05	0.000203	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—pancreatic cancer	1.54e-05	0.000201	CcSEcCtD
Ifosfamide—Cough—Epirubicin—pancreatic cancer	1.52e-05	0.000199	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—pancreatic cancer	1.52e-05	0.000199	CcSEcCtD
Ifosfamide—Asthenia—Docetaxel—pancreatic cancer	1.51e-05	0.000198	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—pancreatic cancer	1.51e-05	0.000197	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—pancreatic cancer	1.5e-05	0.000197	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.49e-05	0.000196	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—pancreatic cancer	1.49e-05	0.000195	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—pancreatic cancer	1.49e-05	0.000195	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—pancreatic cancer	1.48e-05	0.000194	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—pancreatic cancer	1.48e-05	0.000194	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—pancreatic cancer	1.48e-05	0.000194	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—pancreatic cancer	1.48e-05	0.000194	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.47e-05	0.000193	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—pancreatic cancer	1.46e-05	0.000192	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—pancreatic cancer	1.45e-05	0.00019	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—pancreatic cancer	1.45e-05	0.000189	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—pancreatic cancer	1.44e-05	0.000189	CcSEcCtD
Ifosfamide—Diarrhoea—Docetaxel—pancreatic cancer	1.44e-05	0.000189	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—pancreatic cancer	1.43e-05	0.000187	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—pancreatic cancer	1.42e-05	0.000186	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—pancreatic cancer	1.42e-05	0.000186	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—pancreatic cancer	1.42e-05	0.000186	CcSEcCtD
Ifosfamide—Infection—Epirubicin—pancreatic cancer	1.41e-05	0.000185	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—pancreatic cancer	1.4e-05	0.000184	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—pancreatic cancer	1.39e-05	0.000183	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—pancreatic cancer	1.39e-05	0.000182	CcSEcCtD
Ifosfamide—Dizziness—Docetaxel—pancreatic cancer	1.39e-05	0.000182	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—pancreatic cancer	1.39e-05	0.000182	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—pancreatic cancer	1.39e-05	0.000182	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—pancreatic cancer	1.38e-05	0.000181	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—pancreatic cancer	1.37e-05	0.00018	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—pancreatic cancer	1.37e-05	0.000179	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—pancreatic cancer	1.37e-05	0.000179	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—pancreatic cancer	1.37e-05	0.000179	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.36e-05	0.000178	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—pancreatic cancer	1.35e-05	0.000177	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—pancreatic cancer	1.35e-05	0.000177	CcSEcCtD
Ifosfamide—Vomiting—Docetaxel—pancreatic cancer	1.34e-05	0.000175	CcSEcCtD
Ifosfamide—Rash—Docetaxel—pancreatic cancer	1.33e-05	0.000174	CcSEcCtD
Ifosfamide—Hypotension—Epirubicin—pancreatic cancer	1.33e-05	0.000174	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—pancreatic cancer	1.33e-05	0.000174	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—pancreatic cancer	1.32e-05	0.000173	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—pancreatic cancer	1.31e-05	0.000172	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.31e-05	0.000172	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—pancreatic cancer	1.3e-05	0.000171	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.29e-05	0.000169	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—pancreatic cancer	1.29e-05	0.000169	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.29e-05	0.000168	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—pancreatic cancer	1.28e-05	0.000167	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—pancreatic cancer	1.27e-05	0.000167	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.27e-05	0.000166	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—pancreatic cancer	1.26e-05	0.000166	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—pancreatic cancer	1.26e-05	0.000165	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—pancreatic cancer	1.25e-05	0.000164	CcSEcCtD
Ifosfamide—Nausea—Docetaxel—pancreatic cancer	1.25e-05	0.000164	CcSEcCtD
Ifosfamide—Decreased appetite—Epirubicin—pancreatic cancer	1.23e-05	0.000162	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—pancreatic cancer	1.23e-05	0.000161	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.22e-05	0.00016	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—pancreatic cancer	1.22e-05	0.00016	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—pancreatic cancer	1.21e-05	0.000159	CcSEcCtD
Ifosfamide—Pain—Epirubicin—pancreatic cancer	1.21e-05	0.000159	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.2e-05	0.000157	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—pancreatic cancer	1.18e-05	0.000154	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—pancreatic cancer	1.17e-05	0.000153	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—pancreatic cancer	1.17e-05	0.000153	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—pancreatic cancer	1.17e-05	0.000153	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.16e-05	0.000152	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—pancreatic cancer	1.14e-05	0.00015	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.13e-05	0.000148	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—pancreatic cancer	1.13e-05	0.000148	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—pancreatic cancer	1.13e-05	0.000148	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—pancreatic cancer	1.12e-05	0.000147	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—pancreatic cancer	1.12e-05	0.000147	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—pancreatic cancer	1.12e-05	0.000147	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—pancreatic cancer	1.12e-05	0.000147	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—pancreatic cancer	1.08e-05	0.000142	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.07e-05	0.000141	CcSEcCtD
Ifosfamide—Hypersensitivity—Epirubicin—pancreatic cancer	1.05e-05	0.000137	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—pancreatic cancer	1.04e-05	0.000137	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—pancreatic cancer	1.04e-05	0.000136	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—pancreatic cancer	1.04e-05	0.000136	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—pancreatic cancer	1.02e-05	0.000133	CcSEcCtD
Ifosfamide—Pruritus—Epirubicin—pancreatic cancer	1e-05	0.000132	CcSEcCtD
Ifosfamide—Diarrhoea—Epirubicin—pancreatic cancer	9.71e-06	0.000127	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—pancreatic cancer	9.67e-06	0.000127	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—pancreatic cancer	9.42e-06	0.000123	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—pancreatic cancer	9.38e-06	0.000123	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—pancreatic cancer	9.29e-06	0.000122	CcSEcCtD
Ifosfamide—Vomiting—Epirubicin—pancreatic cancer	9.02e-06	0.000118	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—pancreatic cancer	8.98e-06	0.000118	CcSEcCtD
Ifosfamide—Rash—Epirubicin—pancreatic cancer	8.95e-06	0.000117	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—pancreatic cancer	8.94e-06	0.000117	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—pancreatic cancer	8.68e-06	0.000114	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—pancreatic cancer	8.43e-06	0.00011	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—pancreatic cancer	8.35e-06	0.000109	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—pancreatic cancer	8.28e-06	0.000108	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—pancreatic cancer	8.27e-06	0.000108	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—pancreatic cancer	7.8e-06	0.000102	CcSEcCtD
